Persistent therapeutic effect of repeated injections of onabotulinum toxin A in refractory bladder pain syndrome/interstitial cystitis

Journal of Urology

Volumn 189, Issue 2, 2013, Pages 548-553

  Pinto, Rui ^a,b   Lopes, Tiago ^a,b   Silva, João ^a,b   Silva, Carlos ^a,b   Dinis, Paulo ^a,b,c   Cruz, Francisco ^a,b,c  

^a HOSPITAL DE SÃO JOÃO   (Portugal)

^b Institute of Histology and Embryology   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

cystitis; interstitial; onabotulinumtoxinA; pain; urinary bladder

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CYSTALGIA; DRUG EFFECT; DRUG EFFICACY; FEMALE; GENERAL ANESTHESIA; HUMAN; INTERSTITIAL CYSTITIS; MICTURITION; NOCTURIA; O LEARY SANT SCORE; PAIN ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; REPEATED DRUG DOSE; SCORING SYSTEM; TREATMENT DURATION; TREATMENT OUTCOME; URINARY FREQUENCY; URINARY TRACT INFECTION; VISUAL ANALOG SCALE;

ADMINISTRATION, INTRAVESICAL; ADULT; AGED; BOTULINUM TOXINS, TYPE A; CYSTITIS, INTERSTITIAL; FEMALE; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 84872132532     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.09.027     Document Type: Article

References (22)

1. J.P. van de Merwe, J. Nordling, P. Bouchelouche Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal Eur Urol 53 2008 60
2. P. Hanno, J. Nordling, M. Fall Bladder pain syndrome Med Clin North Am 95 2011 55
3. A. Giannantoni, V. Bini, R. Dmochowski Contemporary management of the painful bladder: a systematic review Eur Urol 61 2012 29
4. P.M. Hanno, D.A. Burks, J.Q. Clemens AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome J Urol 185 2011 2162
5. A. Apostolidis, P. Dasgupta, P. Denys Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report Eur Urol 55 2009 100
6. Y.C. Chuang, N. Yoshimura, C.C. Huang Intravesical botulinum toxin A administration produces analgesia against acetic acid induced bladder pain response in rats J Urol 172 2004 1529
7. D.E. Rapp, K.W. Turk, G.T. Bales Botulinum toxin type A inhibits calcitonin gene-related peptide release from isolated rat bladder J Urol 175 2006 1138
8. Y. Ikeda, I.V. Zabbarova, L.A. Birder Botulinum neurotoxin serotype A suppresses neurotransmitter release from afferent as well as efferent nerves in the urinary bladder Eur Urol 2012 Epub ahead of print
9. A. Giannantoni, M. Porena, E. Costantini Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year followup J Urol 179 2008 1031
10. H.C. Kuo, M.B. Chancellor Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome BJU Int 104 2009 657
11. R. Pinto, T. Lopes, B. Frias Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis Eur Urol 58 2010 360
12. J.A. Gosling, J.S. Dixon, P.Y. Jen The distribution of noradrenergic nerves in the human lower urinary tract A review Eur Urol 36 1999 23
13. S. Khan, X. Game, V. Kalsi Long-term effect on quality of life of repeat detrusor injections of botulinum neurotoxin-A for detrusor overactivity in patients with multiple sclerosis J Urol 185 2011 1344
14. A. Coelho, P. Dinis, R. Pinto Distribution of the high-affinity binding site and intracellular target of botulinum toxin type A in the human bladder Eur Urol 57 2010 884
15. A. Apostolidis, P. Dasgupta, C.J. Fowler Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity Eur Urol 49 2006 644
16. D.A. Cockayne, P.M. Dunn, Y. Zhong P2X2 knockout mice and P2X2/P2X3 double knockout mice reveal a role for the P2X2 receptor subunit in mediating multiple sensory effects of ATP J Physiol 567 2005 621
17. Y. Sun, T.C. Chai Up-regulation of P2X3 receptor during stretch of bladder urothelial cells from patients with interstitial cystitis J Urol 171 2004 448
18. A. Sahai, C. Dowson, M.S. Khan Repeated injections of botulinum toxin-A for idiopathic detrusor overactivity Urology 75 2010 552
19. C. Dowson, J. Watkins, M.S. Khan Repeated botulinum toxin type A injections for refractory overactive bladder: medium-term outcomes, safety profile, and discontinuation rates Eur Urol 61 2012 834
20. C.S. Gomez, P. Kanagarajah, A. Gousse The use of botulinum toxin A in idiopathic overactive bladder syndrome Curr Urol Rep 11 2010 353
21. A.E. Gousse, P. Kanagarajah, R. Ayyathurai Repeat intradetrusor injections of onabotulinum toxin A for refractory idiopathic overactive bladder patients: a single-center experience Female Pelvic Med Reconstr Surg 17 2011 253
22. J.W. Warren, V. Brown, S. Jacobs Urinary tract infection and inflammation at onset of interstitial cystitis/painful bladder syndrome Urology 71 2008 1085